Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Contemporary Drug Problems is Scopus-indexed (Q1, CiteScore 4.6), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 0091-4509Verify ISSN ↗2163-1808Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: About US$3,400 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Law | 97 / 1162 | 91st | Q1 |
| Health (social science) | 80 / 387 | 79th | Q1 |
| Health Policy | 88 / 330 | 73rd | Q2 |
| Public Health, Environmental and Occupational Health | 200 / 725 | 72nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014–present (also 1994, 1973–1981), best quartile Q1, CiteScore 4.6.
Contemporary Drug Problems is Q1 in Law (rank 97 of 1162), Q1 in Health (social science) (rank 80 of 387) and Q2 in Health Policy (rank 88 of 330), by CiteScore 2025. It is ranked in 4 subject areas in all.
Contemporary Drug Problems is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.6, which places it in quartile Q1 at the 91st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.002, quartile Q1, with an H-index of 28.
The publisher lists an article processing charge of about US$3,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Contemporary Drug Problems is published by SAGE Publications Inc. Its print ISSN is 0091-4509 and its online ISSN is 2163-1808.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Contemporary Drug Problems has an h-index of 48 and a 2-year mean of 1.52 citations per paper (OpenAlex). Its Scopus CiteScore is 4.6, quartile Q1. On 2-year citations it ranks #176 of 1,057 Scopus journals in Law.
Contemporary Drug Problems published 56 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from Australia (18.8%), Canada (18.8%) and United States (14.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.